AstraZeneca PLC (AZN) reported Q4 2025 results with revenue up modestly and strong improvement in profitability. Total revenue came in at $15.5 billion (up 4.11% year-over-year), while operating profit rose to $11.6 billion (up 469.16% YoY). Net income attributable to common shareholders was $2.3 billion (up 55.07% YoY) and diluted earnings per share was $0.75 (up 55.21% YoY).
Balance sheet and cash flow snapshots show solid liquidity but weaker operating cash conversion in the quarter.
Note: This financials data is sourced from a third-party provider and has not been independently verified by Quiver.
AstraZeneca PLC Hedge Fund Activity
We have seen 709 institutional investors add shares of AstraZeneca PLC stock to their portfolio, and 507 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CAPITAL INTERNATIONAL INVESTORS removed 6,352,463 shares (-20.2%) from their portfolio in Q3 2025, for an estimated $487,360,961
- CITIGROUP INC added 2,898,872 shares (+313.7%) to their portfolio in Q3 2025, for an estimated $222,401,459
- PRICE T ROWE ASSOCIATES INC /MD/ removed 2,818,487 shares (-5.4%) from their portfolio in Q3 2025, for an estimated $216,234,322
- BANK OF MONTREAL /CAN/ added 2,695,793 shares (+344.6%) to their portfolio in Q3 2025, for an estimated $206,821,238
- WELLINGTON MANAGEMENT GROUP LLP removed 2,037,720 shares (-5.9%) from their portfolio in Q3 2025, for an estimated $156,333,878
- HOLOCENE ADVISORS, LP added 1,807,565 shares (+41.8%) to their portfolio in Q3 2025, for an estimated $138,676,386
- BANK JULIUS BAER & CO. LTD, ZURICH added 1,790,874 shares (+11190.9%) to their portfolio in Q4 2025, for an estimated $164,635,046
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
AstraZeneca PLC Government Contracts
We have seen $1,293,572 of award payments to $AZN over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- STRENSIQ 80 MG/0.8 ML INJ.: $1,253,613
- THIS PROJECT IS FOR PROCUREMENT OF STORAGE AND STABILITY STUDY OF LIVE ATTENUATED MASTER AND WORKING SEED L...: $39,959
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
AstraZeneca PLC Congressional Stock Trading
Members of Congress have traded $AZN stock 8 times in the past 6 months. Of those trades, 5 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $AZN stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 3 times. They made 3 purchases worth up to $45,000 on 12/18, 11/19, 10/21 and 0 sales.
- REPRESENTATIVE JULIA LETLOW purchased up to $15,000 on 12/08.
- REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 1 purchase worth up to $15,000 on 10/30 and 2 sales worth up to $30,000 on 10/31, 10/30.
- REPRESENTATIVE VAL T. HOYLE sold up to $15,000 on 09/23.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
AstraZeneca PLC Analyst Ratings
Wall Street analysts have issued reports on $AZN in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Jefferies issued a "Buy" rating on 10/27/2025
To track analyst ratings and price targets for AstraZeneca PLC, check out Quiver Quantitative's $AZN forecast page.
